Global Preimplantation Genetic Testing Market to Grow with a CAGR of 8.22% through 2028
Growing demand of In-Vitro Fertilization are the
major drivers for the Global Preimplantation Genetic Testing Market.
According to TechSci Research report, “Preimplantation
Genetic Testing Market –Global Industry
Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, the Global Preimplantation
Genetic Testing Market at USD 557.28 million in 2022 and is anticipated to
project robust growth in the forecast period with a CAGR of 8.22% through 2028.
This can be ascribed to collaborations and partnerships among leading companies
with a diverse approach to merge the expertise of individual companies and to
strengthen their position in the market.
Preimplantation Genetic
Testing is a set of advanced genetic testing techniques used in reproductive
medicine to assess embryos for genetic abnormalities before they are implanted
in the uterus during in vitro fertilization (IVF) procedures. The primary use
of PGT is to help individuals and couples have healthy pregnancies and reduce
the risk of passing on genetic disorders to their children. Significant growth
in the healthcare industry across the globe represents one of the key factors
creating a positive outlook for the market. Furthermore, the increasing demand
for IVF and increased accuracy and reliability industries are also driving the
market growth.
These diagnostics industries are consumer-based, contributing to
the economy by providing testing. Preimplantation Genetic Testing (PGT)
encompasses several different testing methods and techniques that are used to
assess the genetic health of embryos before they are implanted during in vitro
fertilization (IVF) procedures. PGT-A is used to screen embryos for numerical
chromosomal abnormalities, specifically aneuploidies, which involve an abnormal
number of chromosomes. PGT-A commonly utilizes techniques such as fluorescence
in situ hybridization (FISH), array comparative genomic hybridization (aCGH),
and more recently, next-generation sequencing (NGS).
Therefore, Preimplantation
Genetic Testing (PGT) varies around the world and is influenced by factors such
as healthcare infrastructure, cultural attitudes, regulatory policies, and
socio-economic factors. Developed nations with advanced healthcare systems and
higher levels of disposable income tend to have greater demand for PGT. These
countries often have well-established IVF clinics and fertility centers that
offer PGT as part of their services. Screening for Aneuploidies (PGT-A), Detection
of Monogenic Disorders (PGT-M),and Evaluation of Structural Chromosomal
Rearrangements (PGT-SR) is used when one or both parents have structural
chromosomal rearrangements, such as translocations or inversions, which could
lead to imbalanced chromosomal material in embryos. Rapid infrastructural
development across the globe represents one of the key factors stimulating the
growth of the market.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on "Global Preimplantation Genetic Testing Market”
Moreover, leading players operating in the industry are
focusing on technology innovations to offer a better customer experience. They
are also engaging in partnerships and collaborations to increase their brand
presence. Apart from this, PGT-M allows couples who are carriers of genetic
mutations to select embryos that do not carry the mutation, reducing the risk
of passing on the disorder to their children. Examples of PGT-M applications
include cystic fibrosis, sickle cell anemia, and Huntington's disease.
Moreover, PGT-M is employed to identify embryos carrying specific genetic
mutations or monogenic disorders that are known to be present in the family.
Governments worldwide acknowledge the economic and environmental significance
of the Preimplantation Genetic Testing industry and have implemented various
initiatives to foster its production and growth. There is a growing emphasis on
Patient-centered care within the Preimplantation Genetic Testing industry, with
financial benefits such as tax breaks or subsidies being offered to companies
that adopt faster and convenient testing.
Emphasis is placed on research
efforts to advance the understanding of genetic disorders, improve genetic
screening techniques, and address the challenges associated with PGT.
Innovation drives the development of new technologies and methodologies.
Additionally, Genetic counseling is emphasized to provide patients with a clear
understanding of the implications of PGT results. Informed consent processes
ensure that individuals and couples have comprehensive information about the
benefits, risks, and ethical considerations of PGT. The PGT marketplaces an
emphasis on continuous technological advancements in genetic screening methods,
laboratory techniques, and data analysis. Improvements in accuracy, efficiency,
and the scope of genetic testing contribute to the growth of the market.
Collaboration plays a pivotal role in the pursuit of environmental
sustainability within the Preimplantation Genetic Testing industry. Governments
and regulatory bodies focus on establishing clear and ethical regulations for
PGT procedures. These frameworks ensure patient safety, quality standards, and
responsible practice.
Through strategic partnerships, brands, manufacturers,
and preimplantation genetic testing players can collaborate to implement
sustainable practices. International organizations and professional medical
associations emphasize the importance of developing and adhering to global
guidelines for PGT practices. Collaboration ensures consistency, best
practices, and ethical standards across different regions. CPMC’s LRDP (also called the proposed
project) is a multi-pronged strategic plan to: Meet State requirements for
hospital seismic safety (SB 1953). Establish a 20 year framework and
institutional master plan for its four current medical campuses (Sacramento’s
Pacific Campus at the corner of Pacific Avenue and Buchanan Street; California
at Maple Avenue and California Streets; Davies’ Campus at Castro Avenue and
14th Street; St. Luke’s Campus at Caesars Avenue and Valencia Street) Establish
a new proposed medical campus (Van Ness Avenue at Geary Boulevard in San
Francisco).
However, Ethical and
moral concern and limited access and awareness are expected to slow down the
growth of the market in the coming years.
The Global
Preimplantation Genetic Testing Market segmentation is based on Procedure Type,
Product, Technology, Application, End-Use Industry, By Company, and Region.
Some of the major companies
operating in the Global
Preimplantation Genetic Testing Market include:
- California Pacific Medical
Center (CPMC)
- CombiMatrix
- CooperSurgical, Inc.
- F. Hoffmann-La Roche Ltd.
- Genea Limited
- Genesis Genetics
- Good Start Genetics, Inc.
- IGENOMIX
- Illumina, Inc.
- Invitae Corporation
- Laboratory Corporation of
America Holdings
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“Certain regions, particularly the Europe, are
projected to exert significant demand for Preimplantation Genetic Testing
worldwide. The growth in the competitive landscape and the presence of
well-established companies in the market, committed to enhancing their
Preimplantation Genetic Testing productivity each year, are expected to
contribute to a remarkable growth of the Global Preimplantation Genetic Testing
Market in the forecast period," said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based Global management consulting firm.
Preimplantation Genetic
Testing Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2018-2028 Segmented By Procedure (Pre-implantation genetic diagnosis
(PDS), Preimplantation Genetic Screening (PGS)) By Product (Reagents and
Consumables, Instruments, Software), By Technology (Next Generation Sequencing
(NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization
(FISH), Others), By Application (Chromosomal Abnormalities, X-linked Diseases,
Embryo Testing, Aneuploidy Screening, HLA Typing, Other Applications), By
End-Use Industry (Fertility Centers, Hospitals, Diagnostic Centers, Research
Centers and Academic Labs), By Region, Competition has evaluated the future growth potential of
Global Preimplantation Genetic Testing Market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide innovative market intelligence and help decision makers take
sound investment decisions. Besides, the report also identifies and analyzes
the emerging trends along with essential drivers, challenges, and opportunities
in Global Preimplantation Genetic Testing Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com